ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

ClinicalTrials.gov ID: NCT06976216

Public ClinicalTrials.gov record NCT06976216. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 10, 2026, 12:37 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for the Treatment of Cognitive Impairment Associated With Mild to Moderate Alzheimer's Disease (MINDSET 1)

Study identification

NCT ID
NCT06976216
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
586 participants

Conditions and interventions

Interventions

  • KarX-EC Drug
  • KarXT Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
60 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 13, 2025
Primary completion
Sep 10, 2028
Completion
Feb 22, 2029
Last update posted
May 6, 2026

2025 – 2029

United States locations

U.S. sites
28
U.S. states
17
U.S. cities
27
Facility City State ZIP Site status
Healthy Brain Clinic Long Beach California 90804 Recruiting
Anderson Clinical Research Redlands California 92374 Recruiting
Mountain Neurological Research Center Basalt Colorado 81621 Recruiting
Georgetown University Medical Center Washington D.C. District of Columbia 20007 Recruiting
JEM Research Institute Atlantis Florida 33462 Recruiting
VIN-Julie Schwartzbard Aventura Florida 33180 Recruiting
Merritt Island Medical Research, LLC Merritt Island Florida 32952 Recruiting
Renstar Medical Research Ocala Florida 34470 Recruiting
Alzheimer's Research and Treatment Center Stuart Florida 34997 Recruiting
Charter Research - Lady Lake The Villages Florida 32162 Recruiting
Local Institution - 0016 Columbus Georgia 31909 Withdrawn
Center for Advanced Research & Education Gainesville Georgia 30501 Recruiting
Re:Cognition Health - Chicago Chicago Illinois 60611 Recruiting
Ascension Alexian Brothers Elk Grove Village Illinois 60007 Recruiting
Boston Center for Memory Newton Massachusetts 02459 Recruiting
HealthPartners Neuroscience Center Saint Paul Minnesota 55130 Recruiting
Advanced Memory Research Institute of New Jersey Toms River New Jersey 08755 Recruiting
NYU Langone Health New York New York 10016 Recruiting
Local Institution - 0259 New York New York 10029 Active, not recruiting
SUNY Upstate Medical University Syracuse New York 13210 Recruiting
AMC Research, LLC Matthews North Carolina 28105 Recruiting
Ohio State University Columbus Ohio 43221 Recruiting
NDx Clinical Research Inc. Dayton Ohio 45459 Recruiting
Summit Headlands Portland Oregon 97210 Recruiting
Local Institution - 0004 Abington Pennsylvania 19001 Withdrawn
Rhode Island Mood & Memory Research Institute East Providence Rhode Island 02914 Recruiting
Neurology Clinic, P.C. Cordova Tennessee 38018 Recruiting
Gadolin Research Beaumont Texas 77702 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 77 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06976216, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 6, 2026 · Synced May 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06976216 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →